BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32529242)

  • 1. Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity.
    van der Heijden CDCC; Ter Horst R; van den Munckhof ICL; Schraa K; de Graaf J; Joosten LAB; Danser AHJ; Netea MG; Deinum J; Rutten J; Riksen NP
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2719-31. PubMed ID: 32529242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.
    Grotevendt A; Wallaschofski H; Reincke M; Adolf C; Quinkler M; Nauck M; Hoffmann W; Rettig R; Hannemann A
    Endocrine; 2017 Aug; 57(2):298-307. PubMed ID: 28638984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin and aldosterone are not associated with vulnerable plaque characteristics in patients with carotid artery disease.
    Hillaert MA; den Ruijter HM; Hoefer IE; Lentjes EG; de Borst GJ; de Vries JPM; Doevendans PA; Pasterkamp G; Timmers L
    J Vasc Surg; 2018 Jul; 68(1):128-135. PubMed ID: 29548814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism.
    Vecchiola A; Fuentes CA; Barros ER; Martínez-Aguayo A; García H; Allende F; Solari S; Olmos R; Carvajal C; Tapia-Castillo A; Campino C; Kalergis AM; Baudrand R; Fardella CE
    Am J Hypertens; 2019 Apr; 32(5):468-475. PubMed ID: 30753255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Clonal Hematopoiesis Driver Mutations, Immune Cell Function, and the Vasculometabolic Complications of Obesity.
    Tercan H; Cossins BC; van Deuren RC; Rutten JHW; Joosten LAB; Netea MG; Hoischen A; Bekkering S; Riksen NP
    J Am Heart Assoc; 2024 Jan; 13(2):e031665. PubMed ID: 38214284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-Specific Regulation of Inflammation and Metabolic Syndrome in Obesity.
    Ter Horst R; van den Munckhof ICL; Schraa K; Aguirre-Gamboa R; Jaeger M; Smeekens SP; Brand T; Lemmers H; Dijkstra H; Galesloot TE; de Graaf J; Xavier RJ; Li Y; Joosten LAB; Rutten JHW; Netea MG; Riksen NP
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1787-1800. PubMed ID: 32460579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism.
    van der Heijden CDCC; Smeets EMM; Aarntzen EHJG; Noz MP; Monajemi H; Kersten S; Kaffa C; Hoischen A; Deinum J; Joosten LAB; Netea MG; Riksen NP
    J Clin Endocrinol Metab; 2020 May; 105(5):e1967-80. PubMed ID: 31875423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannose-binding lectin in obesity with different degrees of metabolic syndrome abnormalities: association with atherogenic and metabolic traits.
    Strack C; Baessler A; Wagner F; Bruxmeier J; Yaroslavskii O; Rousseva E; Loew T; Riegger G; Schmitz G; Fischer M
    J Atheroscler Thromb; 2012; 19(6):539-51. PubMed ID: 22472212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of Plasma Renin Activity to Subclinical Peripheral and Coronary Artery Disease (from the Multiethnic Study of Atherosclerosis).
    Unkart JT; Allison MA; Abdelmalek JA; Jenny NS; McClelland RL; Budoff M; Ix JH; Rifkin DE
    Am J Cardiol; 2020 Jun; 125(12):1794-1800. PubMed ID: 32307090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL-C, ApoA1 and VLDL-TG as biomarkers for the carotid plaque presence in patients with metabolic syndrome.
    Abi-Ayad M; Abbou A; Abi-Ayad FZ; Behadada O; Benyoucef M
    Diabetes Metab Syndr; 2018; 12(2):175-179. PubMed ID: 29338972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical utility of two renin mass methods to detect primary hyperaldosteronism compared with renin activity.
    Wedatilake YN; Scanlon MJ; Barnes SC
    Ann Clin Biochem; 2011 May; 48(Pt 3):256-62. PubMed ID: 21427267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.
    Gonçalves I; Edsfeldt A; Colhoun HM; Shore AC; Palombo C; Natali A; Fredrikson GN; Björkbacka H; Wigren M; Bengtsson E; Östling G; Aizawa K; Casanova F; Persson M; Gooding K; Gates P; Khan F; Looker HC; Adams F; Belch J; Pinnola S; Venturi E; Kozakova M; Gan LM; Schnecke V; Nilsson J;
    BMC Cardiovasc Disord; 2016 Sep; 16(1):171. PubMed ID: 27596252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study.
    Then C; Rottenkolber M; Lechner A; Meisinger C; Heier M; Koenig W; Peters A; Rathmann W; Bidlingmaier M; Reincke M; Seissler J
    Atherosclerosis; 2016 Sep; 252():88-96. PubMed ID: 27508320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of renin angiotensin aldosterone system disorders in young hypertensives.
    Gilani M; Asif N; Akram A; Gilani M; Ijaz A; Malik SS
    J Pak Med Assoc; 2018 Aug; 68(8):1179-1182. PubMed ID: 30108382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased aldosterone/renin quotient in obese hypertensive women: a novel role for low-density lipoproteins?
    Lamounier-Zepter V; Rotthoff T; Ansurudeen I; Kopprasch S; Scherbaum WA; Ehrhart-Bornstein M; Bornstein SR
    Horm Metab Res; 2006 Jul; 38(7):471-5. PubMed ID: 16933186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Zelzer S; Enko D; Pilz S; Tomaschitz A; März W; Meinitzer A
    Clin Biochem; 2017 Sep; 50(13-14):739-745. PubMed ID: 28322753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo and Ex Vivo Inflammatory Markers of Common Metabolic Phenotypes in Humans.
    Mærkedahl RB; Frøkiær H; Stenbæk MG; Nielsen CB; Lind MV; Lundtoft C; Bohr MB; Ibrügger S; Metzdorff SB; Vestergaard H; Pedersen O; Lauritzen L
    Metab Syndr Relat Disord; 2018 Feb; 16(1):29-39. PubMed ID: 29319419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First?
    De Pergola G; Cortese F; Termine G; Meliota G; Carbonara R; Masiello M; Cortese AM; Silvestris F; Caccavo D; Ciccone MM
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):251-259. PubMed ID: 29437024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The associations of adipokines with selected markers of the renin-angiotensinogen-aldosterone system: the multi-ethnic study of atherosclerosis.
    Allison MA; Jenny NS; McClelland RL; Cushman M; Rifkin D
    J Hum Hypertens; 2015 Feb; 29(2):127-33. PubMed ID: 24919752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet magnesium depletion in normotensive and hypertensive obese subjects: the role of salt-regulating hormones and catecholamines.
    Corica F; Corsonello A; Buemi M; De Gregorio T; Malara A; Mauro VN; Macaione S; Ientile R
    Magnes Res; 1999 Dec; 12(4):287-96. PubMed ID: 10612086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.